The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond
View original at nasdaq.comThe Best High-Yield Dividend Stocks to Buy for 2026 and Beyond Key Points AbbVie provides an attractive combination of income, value, and growth…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Enbridge has visible growth through the end of the decade, with roughly $50 billion of opportunities identified
60% confidenceThe 10 stocks identified by Stock Advisor could produce monster returns in the coming years
60% confidenceNow is a great time to invest in dividend stocks with above-average yields
60% confidenceThe Federal Reserve is virtually paralyzed by uncertainty about inflation and the job market
60% confidenceRealty Income has particularly promising opportunities in Europe, where the total addressable market is $8.5 trillion and competition is limited
60% confidenceEnbridge expects to deliver growth across all aspects of its business, especially in natural gas transmission
60% confidenceAbbVie should deliver solid growth over the next few years driven by drugs like Rinvoq and Skyrizi and promising late-stage pipeline programs
60% confidence
Data points we hold from this source
| S&P 500 · healthcare sector forward pe ratio | 17.4 ratio |
| S&P 500 · forward pe ratio | 20 ratio |
| AbbVie Inc. · dividend increase streak | 53 years |
| AbbVie Inc. · forward pe ratio | 14.3 ratio |